Xihan Liu - Publications

Development of a prediction model for recurrence in patients with malignant ovarian germ cell tumors undergoing fertility-sparing surgery: A multicenter retrospective study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: April 20, 2026

Development of a novel immune infiltration-based gene signature to predict prognosis and immunotherapy response of a novel anti-PD-L1/TGF-β bifunctional fusion protein in recurrent cervical cancer.

Journal: Human vaccines & immunotherapeutics

Published: March 23, 2026

TFAP2C protects against ferroptosis in ovarian cancer through the KEAP1-NRF2 axis by recruiting HDAC1/2.

Journal: Oncogene

Published: September 09, 2025

5-methylcytosine regulated CCNL2 promotes tumorigenesis and cisplatin resistance of ovarian cancer with therapeutic implications.

Journal: Journal of ovarian research

Published: March 21, 2025

Lysosomal dysfunction and overload of nucleosides in thymidine phosphorylase deficiency of MNGIE.

Journal: Journal of translational medicine

Published: February 20, 2024

Splicing Factor PQBP1 Curtails BAX Expression to Promote Ovarian Cancer Progression.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 31, 2023

Distinctive metabolic remodeling in TYMP deficiency beyond mitochondrial dysfunction.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: January 02, 2023

Medical Education Systems in China: Development, Status, and Evaluation.

Journal: Academic medicine : journal of the Association of American Medical Colleges

Published: August 10, 2022

Immune and inflammation: related factor alterations as biomarkers for predicting prognosis and responsiveness to PD-1 monoclonal antibodies in cervical cancer.

Journal: Discover oncology

Published: June 14, 2022

Effect of Tumor Size on Long-Term Survival After Resection for Solitary Intrahepatic Cholangiocarcinoma.

Journal: Frontiers in oncology

Published: May 07, 2020

Mesencephalic Astrocyte-Derived Neurotrophic Factor, a Prognostic Factor of Cholangiocarcinoma, Affects Sorafenib Sensitivity of Cholangiocarcinoma Cells by Deteriorating ER Stress.

Journal: OncoTargets and therapy

Published: January 10, 2020

Diagnostic and Prognostic Values of MANF Expression in Hepatocellular Carcinoma.

Journal: BioMed research international

Published: October 29, 2019